Safety Data Sheet - Gold Biotechnology€¦ · Gold Biotechnology St. Louis, MO Ph: (3 14)8 90-8778...

Gold BiotechnologySt. Louis, MO

Ph: (314)890-8778Web: www.goldbio.com

Email: [email protected]

Safety Data SheetSDS Revision 1.1 Revision Date: 2/3/2015

Section 1: Chemical Identification1.1 Chemical IdentificationProduct Name: 6-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium saltAlternative Names: Salmon-β-D-GlcACatalog Number: C-200

1.2 Relevant Uses and Uses Advised AgainstRecommended Use: This product is not for use in humans. It is for research purposes only.

1.3 Supplier Contact InformationDistributed by: Gold Biotechnology, Inc.

1328 Ashby Rd.St. Louis, MO 63132

Phone: (314) 890-8778Fax: (314) 890-0503Email: [email protected]

1.4 Emergency Contact InformationEmergency Phone: (800)248-7609 Mon.-Fri., 9am-5pm CST

Section 2: Hazardous Information2.1 GHS Classification

To the best of our knowledge the toxicological properties of this material have not beenthoroughly investigated.

2.2 Potential Health EffectsEye: May cause eye irritation.Skin: May cause skin irritationIngestion: Toxicological properties of this substance have not been fully

Investigated.Inhalation: Toxicological properties of this substance have not been fully

investigated.

2.3 HMIS ClassificationHealth hazard: Not AvailableChronic health hazard: Not AvailableFlammability: Not AvailablePhysical hazards: Not Available

mailto:[email protected]

http://www.goldbio.com/


Gold Biotechnology SDS Version 1.16-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium salt SDS Date: 2/3/2015FM-00002 / C-200 of 7




2

2.4 NFPA RatingHealth Hazard: Not AvailableFire: Not AvailableReactivity Hazard: Not Available

Section 3: Composition/Information on Ingredients3.1 CompositionIdentity: 6-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium saltSynonyms: Salmon-β-D-GlcACAS number: 138182-20-4Molecular Formula: C14H14ClNO7 · C6H13NMolecular Weight: 442.90 g/mol

Section 4: First Aid Measures4.1 Detailed First Aid MeasuresInhalation: If breathed in, move person into fresh air. If not breathing, give artificial

respiration. Consult a physician.

Skin: Wash off with soap and plenty of water. Consult a physician.

Eye: Immediately flush eyes with plenty of water for at least 15 minutes,occasionally lifting the lower eyelids. Consult a physician.

Ingestion: Never give anything by mouth to an unconscious person. If victim isconscious and alert, give 2-4 cups full of milk or water. Consult aphysician.

4.2 Most Important Symptoms And Effects, Either Acute Or DelayedThe most important known symptoms and effects are described in the labeling (see section2).And /or in section 11.

4.3 Indication of immediate medical attention and special treatment neededNot available

Section 5: Fire Fighting Measures5.1 Suitable extinguishing media:Use water spray, alcohol resistant foam, dry chemical or carbon dioxide.

5.2 Specific hazards arising from the chemical:Carbon oxides, nitrogen oxides (NOx)

5.3 Special protective actions for fire-fighters:Wear self-contained breathing apparatus for firefighting if necessary.







3

Section 6: Accidental Release Measures6.1 Personal precautions, protective equipment and emergency procedures:Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas.Ensure adequate ventilation. Avoid breathing dust. For personal protection see section 8.

6.2 Environmental precautions:Do not let product enter drains.

6.3 Methods and materials for containment and cleaning up:Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitableclosed containers for disposal.

Section 7: Handling and Storage7.1 Precautions for safe handling:Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriateexhaust ventilation at places where dust is formed. For precautions, see section 2.

7.2 Conditions for safe storage, including any incompatibilities:Keep container tightly closed in a dry and well-ventilated place.

Recommended storage at temperature: -20°C

Keep in a dry place.

Section 8: Exposure Controls / Personal Protection8.1 Control parameters:Contains no substances with occupational exposure limit values.

8.2 Appropriate engineering controls:Handle in accordance with good industrial hygiene and safety practice. Wash hands beforebreaks and at the end of the workday.

8.3 Personal Protective Equipment (PPE):Eye/Face Protection: Safety glasses with side-shields conforming to EN166. Use ofequipment for eye protection tested and approved under appropriate governmentstandards such as NIOSH (US) or EN166 (EU).

Skin Protection: Handle with gloves. Gloves must be inspected prior to use. Use properglove removal technique (without touching glove’s outer surface) to avoid skin contactwith this product. Dispose of contaminated gloves after use in accordance withapplicable laws and good laboratory practices. Wash and dry hands.

Body Protection: Complete suit protecting against chemicals, the type of protective







4

Equipment must be selected according to the concentration and amount of theDangerous substance at the specific workplace.

Respiratory Protection: For nuisance exposures, use type P95 (US) or type P1(EU EN 143) particle respirator. For higher level protection, use type OV/AG/P99(US) or type ABEK-P2 (US EN 143) respirator cartridges. Use respirators andcomponents tested and approved under appropriate government standards such asNIOSH (US) or CEN (EU).

Section 9: Physical and Chemical Properties9.1 General chemical and physical properties

Appearance: Off-white to slightly yellow powderOdor: Not availableOdor Threshold: Not availablepH: Not availableMelting Point: Not availableFreezing Point: Not availableBoiling Point/Range: Not availableFlash Point: Not availableEvaporation Rate: Not availableLower Explosion Limit: Not availableUpper Explosion Limit: Not availableVapor Pressure: Not availableVapor Density: Not availableRelative Density: Not availableSolubility: Not availablePartition Coefficientn-octanol/water: Not availableAuto-IgnitionTemperature: Not availableDecompositionTemperature: Not availableViscosity: Not available

Section 10: Stability and Reactivity Data10.1 Reactivity:Not available

10.2 Chemical Stability:Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions:Not available







5

10.4 Conditions to avoid:Incompatible materials, moisture, light

10.5 Incompatible materials:Strong oxidizing agents.

10.6 Hazardous decomposition products:Other decomposition products – not availableIn the event of fire: See section 5.

Section 11: Toxicological Information11.1 Toxicological effectsAcute toxicity:

Not Available

Skin corrosion/irritation:Not available

Respiratory or skin sensitization:Not available

Germ cell mutagenicity:Result: Not mutagenic in Ames Test.Histidine reversion (Ames)

Carcinogenicity:IARC: No component of this product present at levels greater than or equal

to 0.1% is identified as probable, possible or confirmed carcinogen byIARC.

ACGIH: No component of this product present at levels greater than or equalto 0.1% is identified as probable, possible or confirmed carcinogen byACGIH.

NTP: No component of this product present at levels greater than or equalto 0.1% is identified as probable, possible or confirmed carcinogen byNTP.

OSHA: No component of this product present at levels greater than or equalto 0.1% is identified as probable, possible or confirmed carcinogen byOSHA.

Reproductive toxicity:Not available

STOT-single exposure:







6

Not available

STOT-repeated exposure:Not available

Aspiration hazard:Not available

Section 12: Ecological Information12.1 Toxicity:

Not Available

12.2 Persistence and degradability:Not available

12.3 Bioaccumulative potential:Not available

12.4 Mobility in soil:Not available

12.5 Other adverse effects:Not available

Section 13: Disposal ConsiderationsOffer surplus and nonrecyclable solutions to a licensed disposal company.

Section 14: Transport Information14.1 US Department of Transportation (DOT):

Not dangerous goods

14.2 International Maritime Dangerous Goods (IMDG):Not dangerous goods

14.3 International Air Transport Association (IATA):Not dangerous goods

Section 15: Regulatory InformationSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section302.

SARA 313 Components:This material does not contain any chemical components with known CAS numbers that







7

exceeds the threshold (DeMinimis) reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards:No SARA Hazards

Massachusetts Right To Know Components: CAS - No.6-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium salt 138182-20-4

Pennsylvania Right To Know Components: CAS - No.6-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium salt 138182-20-4

New Jersey Right To Know Components: CAS - No.6-Chloro-3-indoxyl-beta-D-glucuronic acid, cyclohexylammonium salt 138182-20-4

California Prop. 65 Components:This product does not contain any chemicals known to the State of California to cause cancer,birth defects or any other reproductive harm.

Section 16: Other InformationWhile Gold Biotechnology, Inc. believes the information contained herein to be true and accurate, it hasrelied on information provided by others. Gold Biotechnology, INC. makes no warranties, express orimplied, as to the accuracy or adequacy of the information contained herein or with respect to theresults to be obtained from the use of the product. Gold Biotechnology, Inc. disclaims all liability withrespect to the use of this product, including without limitation, liability for injury to the user or third-party persons.

Preparation InformationGold BiotechnologyContent/Marketing Department(800) 248-7609Last updated: 2/3/2015



Safety Data Sheet - Gold Biotechnology€¦ · Gold Biotechnology St. Louis, MO Ph: (3 14)8 90-8778...

Documents

Transcript of Safety Data Sheet - Gold Biotechnology€¦ · Gold Biotechnology St. Louis, MO Ph: (3 14)8 90-8778...